Centene Raises 2026 GAAP and Adjusted EPS Guidance After Q3
Centene reported Q3 GAAP diluted EPS of $(0.14) and adjusted EPS of $0.58. It raised 2026 GAAP EPS guidance to >$3.46 and adjusted EPS guidance to >$5.20.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Centene Q3 Earnings
Adj EPS: 58c (est 7c) - Rev: $50.65B (est $46.96B) - Health Benefits Ratio: 92.7% (est 92.4%) - Sees FY Revenue: $196.5B To $200.5B (prev $193.5B To $197.5B)
Centene Q3'26 Earnings Preview: EPS Estimated at 0.10 USD
Centene is scheduled to report Q3'26 results on October 27 before the market opens. Revenue is estimated at 47.12 billion USD and EPS at 0.10 USD.